JHM Biopharmaceutical (Hangzhou) Co., Ltd.（hereinafter referred to as “JHM”) is a business dedicated to the development and commercialization of innovative synthetic biology products and technologies. JHM is committed to advancing the use of innovative recombinant protein drugs in endocrine therapy, neurotherapy, and other next-generation biomedical material applications. Our mission is to provide groundbreaking biopharmaceutical products and treatments to patients worldwide.
JHM adheres to a patient-centered approach, driven by technological innovation. The company focuses on healthcare applications, accelerating the development of its product pipeline and striving for industry leadership in the field of recombinant protein drugs.
Dr. Leng Chunsheng, Founder
